Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)


Open article in different language:  DE  |  FR  |  IT
Art. 55 Integrity 132

1 Per­sons who pre­scribe, dis­pense, use or pur­chase for this pur­pose pre­scrip­tion medi­cin­al products, and or­gan­isa­tions em­ploy­ing such per­sons shall not claim, be prom­ised or ac­cept any un­due ad­vant­age for them­selves or for the be­ne­fit of a third party. Sim­il­arly, it is for­bid­den to of­fer, prom­ise or grant an un­due ad­vant­age to any such per­son or or­gan­isa­tion for their be­ne­fit or for the be­ne­fit of a third party.

2 The fol­low­ing are not re­garded as un­due ad­vant­ages:

a.
ad­vant­ages of mod­est value which are of rel­ev­ance to med­ic­al or phar­ma­ceut­ic­al prac­tice;
b.
sup­port for re­search, edu­ca­tion and train­ing, provided that cer­tain cri­ter­ia are met;
c.
com­pens­a­tion for equi­val­ent ser­vices in re­turn, in par­tic­u­lar for those provided in con­nec­tion with or­ders and de­liv­er­ies of thera­peut­ic products;
d.
price dis­counts or re­funds gran­ted on med­ic­al pur­chases, provided they have no in­flu­ence on the choice of treat­ment.

3 The Fed­er­al Coun­cil shall reg­u­late the de­tails. It may ex­tend the ap­plic­ab­il­ity of para­graphs 1 and 2 to oth­er cat­egor­ies of thera­peut­ic products.

132 In­ser­ted by No I of the FA of 18 March 2016, in force since 1 Jan. 2020 (AS 2017 2745, 2019 1393; BBl 2013 1).

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden